| Financial Year |
March 31 2023 |
| Monetary Funds |
63,363,542.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
15,584,540.82 |
| Accounts Receivable |
126,675,479.13 |
| Advances to Suppliers |
25,545,650.12 |
| Other Receivables |
69,251,229.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
289,030,421.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,291,819.14 |
| Total Current Assets |
610,593,710.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,799,653.65 |
| Fixed Assetes |
507,930,516.12 |
| Under-construction Projects |
452,991,940.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
156,517,834.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
36,065,139.06 |
| Other Non-Current Assets |
20,788,785.18 |
| Sub-Total of Non-Current Assets |
1,183,557,217.92 |
| Total Assets |
1,794,150,928.61 |
| Short-Term Loans |
167,600,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,000,000.00 |
| Accounts Payable |
802,888,867.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,364,702.44 |
| Taxes Payable |
17,487,686.61 |
| Interest Payable |
-- |
| Dividend Payable |
81,600.00 |
| Other payables |
591,296,308.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
383,571.17 |
| Other Current Liabilities |
10,626,379.40 |
| Sub-Total of Current Liabilities |
1,689,752,965.91 |
| Long-term Loans |
37,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,363,126.25 |
| Total Liabilities |
1,771,116,092.16 |
| Paid-In Capital(Or Share Stock) |
552,960,000.00 |
| Capital Surplus |
147,449,994.51 |
| Surplus Reserve |
71,956,208.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-761,357,368.94 |
| Minority Stockholder's Interest |
12,026,002.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,008,833.59 |
| Owner's Equity（Stockholder's Equity） |
23,034,836.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,794,150,928.61 |
